<DOC>
	<DOCNO>NCT01849237</DOCNO>
	<brief_summary>Septic shock remain significant clinical problem associate high rate mortality among neutropenic patient despite antimicrobial therapy supportive care . Recently , mesenchymal stromal cell ( MSC ) demonstrate remarkable potential effect sepsis . MSC treatment significantly reduce mortality septic mouse receive appropriate antimicrobial therapy . MSCs reduce systemic inflammatory cytokine level mice , down-regulated inflammation inflammation-related gene ( interleukin-10 , interleukin-6 ) . Bacterial clearance great MSC-treated mouse . Thus , MSCs beneficial effect experimental sepsis suggest MSСs-therapy may effective adjunctive treatment reduce sepsis-related mortality . The safety MSCs prove Graft-versus-host disease treatment MSCs patient bone marrow transplantation . This study hypothesis MSCs reduce organ dysfunction/injury , systemic inflammation mortality patient septic shock severe neutropenia . The main goal study evaluate impact MSCs therapy organ dysfunction/injury , systemic inflammation 28-day mortality patient septic shock severe neutropenia . All patient randomize two group : control group ( standard treatment septic shock ) MSCs-group ( standard treatment septic shock + MSCs infusion 1-2 millions/kg/ day ) .</brief_summary>
	<brief_title>Russian Clinical Trial Mesenchymal Cells Patients With Septic Shock Severe Neutropenia</brief_title>
	<detailed_description>All activity relate human subject research guide ethical principle review approve Federalwide Assurance National Ctr Hematology , FWA00006482 . The goal trial evaluate plasma concentration proinflammatory cytokine interleukin-6 antiinflammatory cytokine interleukin-10 , plasma level blood creatinine , bilirubin , procalcitonin , C-reactive protein . Then evaluate requirement renal replacement therapy , requirement mechanical ventilation non-invasive mechanical ventilation , pulmonary function-coefficient , partial oxygen pressure arterial blood level , electrocardiograms , Kaplan - Meier curve,28-days mortality .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>septic shock ≤10 h onset septic shock severe neutropenia ( ≤ 1 10^9/l ) Patients ≥17 year Signed Informed Consent treatment oncohematological patient resistance chemotherapy Unsigned Informed Consent treatment Age &gt; 75 year ; Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Mesenchymal Stromal Cells</keyword>
	<keyword>Septic Shock</keyword>
	<keyword>Neutropenia</keyword>
	<keyword>Procalcitonin</keyword>
	<keyword>Interleukin-6</keyword>
	<keyword>Interleukin-10</keyword>
	<keyword>C-reactive protein</keyword>
	<keyword>Survival</keyword>
	<keyword>Organ dysfunction</keyword>
</DOC>